InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.18
(
0.50%
)
Bitcoin
63,968.90
(
0.12%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

buckiii2

Send PM Follow Ignore
Followers 59
Posts 4696
Boards Moderated 0
Alias Born 04/27/2009

buckiii2

Re: None

Wednesday, 04/11/2018 12:12:30 AM

Wednesday, April 11, 2018 12:12:30 AM

Post# of 20775
vTv Therapeutics, Inc. (Nasdaq:VTVT) shares closed down 78% to $0.71 following its announcement after hours Monday that data from Part A of its Phase 3 trial of azeliragon in people with mild Alzheimer’s disease did not meet its co-primary efficacy endpoints.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up